Consistent with this idea, the LYL1 promoter contains ETS and GATA binding sites, which promote the expression of LYL1 in HSCs and both ETS1 and GATA3 are implicated in T-ALL (88–90). Here, GATA3 is linked to acute lymphoblastic leukemia.